Trials / Sponsors / InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Multiple Sclerosis, Relapsing Remitting | Phase 2 | 2015-02-01 |
| Completed | A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparato Type 2 Diabetes Mellitus | Phase 2 | 2008-02-01 |
| Completed | A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus Diabetes Mellitus, Type II | Phase 2 | 2003-12-01 |